Cantor Fitzgerald initiated coverage on Apricus Biosciences (NASDAQ: APRI) with a Hold rating and a price target of $2.00.
This article: 187 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE